Skip to content

Frontlight ResearchEarly access

Trial site

Institut Claudius Regaud (Site 3200)

Toulouse, Haute-Garonne 31059, FranceNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Kidney cancer

Closed trials

Completed
Substudy 03B: A Study of Immune and Targeted Combination Therapies in Participants With Second Line Plus (2L+) Renal Cell Carcinoma (MK-3475-03B/KEYMAKER-U03)
NCT04626518· Phase 1/2· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Institut Claudius Regaud (Site 3200): trial site – Frontlight Research